SBIR/STTR Research Award
OTHER FUNCTIONS: PERSEVERE: PERSONALIZED SELF-EFFICACY VIRTUAL ENVIRONMENT RECOVERY EXPERIENCE, N43DA-12-4416.
Award amount
$150,000Program and phase
SBIR · Phase IAward year
2012Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Intelligent Automation, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- C3QJD7VXG167
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
Illegal drugs, alcohol and tobacco are substances that have an impact on both the user and those in a user's vicinity. Recent research indicates that immersive environments utilizing substance aversion gestures can reduce cravings. One theory for these findings relates to research on abstinence self-efficacy. The Personalized Self-Efficacy Virtual Environment Recovery Experience (PERSEVERE) program aims to integrate abstinence self-efficacy research into a serious game.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- ISLE Platform: Immersive Simulation of Lifelike Experience
- Magnesium Alloys for Additive Manufacturing by Artificial Intelligence (MAGAMAI)
- MINT– A software-defined integration architecture for 5G-supported military network
- ACT: An Artificial Intelligence based Course of Action Tool
- MAEDICS: Medic Automated Encounter Documentation, Interpretations, and Communication System
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
1,182 SBIR/STTR records share this UEI (1987–2021). Reported award amounts total $369,972,257. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Transportation, Department of Health and Human Services, National Science Foundation, Department of Homeland Security